ATCC, known as Advancing Tomorrow’s Cure Community, is a community established to study how Asian genetics react to current medicines. Your deidentified sample will be stored indefinitely as anonymous specimens for the option of being able to update your report at the minimal cost after the first FOC update with joining the ATCC, as well as for research purposes. Only an identification specimen number will be used, ensuring the anonymity and privacy of your data. As for the possibility of research direction changes leading to activities related to cloning, Malaysia does not support human cloning therefore we will not be embarking on this area of research. Pharmacogenomics primarily focuses on understanding how an individual’s genetic makeup influences their response to drugs, optimising drug therapy based on genetic factors, and advancing personalized medicine. While research directions can evolve over time, the core focus of pharmacogenomics remains centered on drug response and genetic variability.